Submission for Office of Management and Budget Review; Generic for Administration for Children and Families Program Monitoring Activities (Office of Management and Budget #: 0970-0558), 69931-69932 [2023-22382]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 194 / Tuesday, October 10, 2023 / Notices
be accessible to the public in one place.
Under this new requirement, agencies
will continue their current practice of
submitting printed, signed copies of
mandated reports directly to Congress
and committees and subcommittees. All
resources related to congressionally
mandated reports for Federal agencies
can be found at https://www.gpo.gov/
congressionally-mandated-reports. For
questions, please use the
Congressionally Mandated Reports
submission portal: https://ask.gpo.gov/
s/CMR. Click the drop down arrow next
to Ask a Question, and then select
Agency User or Congressional User.
Hugh Nathanial Halpern,
Director, U.S. Government Publishing Office.
[FR Doc. 2023–22336 Filed 10–6–23; 8:45 am]
BILLING CODE 1520–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with regulatory
provisions, the Centers for Disease
Control and Prevention (CDC)
announces the following meeting of the
Healthcare Infection Control Practices
Advisory Committee (HICPAC). This is
a virtual meeting. The public is
welcomed to listen to the meeting live
via webcast on the World Wide Web.
The webcast link can be found on the
HICPAC website at www.cdc.gov/
hicpac/meeting.html. Time will be
available for public comment.
DATES: The meeting will be held on
November 2, 2023, 9 a.m. to 5 p.m.,
EDT, and November 3, 2023, 9 a.m. to
12 p.m., EDT.
ADDRESSES: The meeting will be
webcast live via the World Wide Web.
The webcast link can be found on the
HICPAC website at www.cdc.gov/
hicpac/meeting.html.
FOR FURTHER INFORMATION CONTACT:
Sydnee Byrd, M.P.A., HICPAC, Division
of Healthcare Quality Promotion,
NCEZID, CDC, l600 Clifton Road NE,
Mailstop H16–3, Atlanta, Georgia 30329,
Telephone (404) 718–8039. Email:
hicpac@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Committee is charged
with providing advice and guidance to
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:39 Oct 06, 2023
Jkt 262001
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, and the Secretary,
Health and Human Services, regarding
(1) the practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters to be Considered: The agenda
will include updates on CDC’s activities
for prevention of healthcare-associated
infections. It will also include updates
from the following HICPAC workgroups:
the Isolation Precautions Guideline
workgroup, the Dental Unit Waterline
Guideline Workgroup, the Healthcare
Personnel Guideline Workgroup, and
the National Healthcare Safety Network
(NHSN) Workgroup. The agenda also
includes updates on CDC and DHQP
activities. Agenda items are subject to
change as priorities dictate.
Public Participation
Oral Public Comment: This meeting
will include time for members of the
public to make an oral comment.
Priority will be given to individuals
who submit a request to make an oral
public comment before the meeting
according to the following procedures:
All persons interested in making an oral
public comment at the November 2–3,
2023 HICPAC meeting must submit a
request between October 2, 2023 and
October 22, 2023, at https://
www.cdc.gov/hicpac/meeting.html no
later than 11:59 p.m., EDT, October 22,
2023, according to the instructions
provided on the HICPAC website. If the
number of persons requesting to speak
is greater than can be reasonably
accommodated during the scheduled
time, CDC will conduct a random draw
to determine the speakers for the
scheduled public comment session.
CDC staff will notify individuals
regarding their request to speak by email
on October 30, 2023. To accommodate
the significant interest in participation
in the oral public comment session of
HICPAC meetings, each speaker will be
limited to three minutes, and each
speaker may only speak once per
meeting.
Written Public Comment: The public
is welcome to submit written comments
in advance of the meeting. The written
public comment period will open
November 1, 2023, and will close at
11:59 p.m., EDT on November 6, 2023.
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
69931
Comments should be submitted in
writing by email to the HICPAC inbox
at hicpac@cdc.gov. All requests must
contain the name, address, and
organizational affiliation of the speaker,
as well as the topic being addressed.
Written comments should not exceed
one single-spaced typed page in length.
Written comments received in advance
of the meeting will be included in the
official record of the meeting.
The Director, Office of Strategic
Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business
Initiatives, Office of the Chief Operating
Officer, Centers for Disease Control and
Prevention.
[FR Doc. 2023–22327 Filed 10–6–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for Office of Management
and Budget Review; Generic for
Administration for Children and
Families Program Monitoring Activities
(Office of Management and Budget #:
0970–0558)
Office of Planning, Research,
and Evaluation, Administration for
Children and Families, U.S. Department
of Health and Human Services.
AGENCY:
ACTION:
Request for public comments.
The Administration for
Children and Families (ACF) intends to
request from the Office of Management
and Budget (OMB) an extension of
approval for an umbrella generic
clearance for information collections
related to ACF program office
monitoring activities. ACF programs
promote the economic and social wellbeing of families, children, individuals,
and communities. The Generic for ACF
Program Monitoring Activities allows
ACF program offices to collect
standardized information from
recipients that receive federal funds to
ensure oversight, evaluation, support
purposes, and stewardship of federal
funds. There are no changes proposed to
SUMMARY:
E:\FR\FM\10OCN1.SGM
10OCN1
69932
Federal Register / Vol. 88, No. 194 / Tuesday, October 10, 2023 / Notices
the terms of the generic. Burden
estimates have been updated.
DATES: Comments due within 30 days of
publication. OMB must make a decision
about the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication.
Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review-Open
for Public Comments’’ or by using the
search function. You can also obtain
copies of the proposed collection of
information by emailing
ADDRESSES:
collection activity under this generic
clearance. Each request will include the
individual form(s) or instrument(s), a
justification specific to the individual
information collection, and any
supplementary documents. OMB is
requested to review requests within 10
days of submission.
Respondents: ACF funding recipients.
Annual Burden Estimates
This request will extend approval of
currently approved monitoring forms.
Currently approved forms and related
burden can be found here: https://
www.reginfo.gov/public/do/
PRAICList?ref_nbr=202307-0970-014.
Burden estimates for the next three
years have been updated to reflect
trends in use over the past three years.
These are based on averages and actual
individual requests will vary based on
program office need.
Instrument
Number of
respondents
(total over
request
period)
Number of
responses per
respondent
(total over
request
period)
Avg. burden
per response
(in hours)
Total burden
(in hours)
New Program Monitoring Forms ....................................................................
1600
2.5
12
48,000
Mary B. Jones,
ACF/OPRE Certifying Officer.
year information. This document
corrects that error.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2023–22382 Filed 10–6–23; 8:45 am]
FOR FURTHER INFORMATION CONTACT:
Casi
Alexander, Office of Digital
Transformation, Food and Drug
Administration, FDA Library, 5630
Fishers Lane, Rm. 1087, Rockville, MD
20857, 240–402–5171, email:
Casi.Alexander@fda.hhs.gov.
Food and Drug Administration
In the
Federal Register of September 19, 2023
(88 FR 64435), in FR Doc. 2023–20136,
the following correction is made:
On page 64436, in the third column,
in the second paragraph, ‘‘Fiscal Years
2024–2026’’ is corrected to read ‘‘Fiscal
Years 2024–2027.’’
AGENCY:
BILLING CODE 4184–79–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
SUPPLEMENTARY INFORMATION:
[Docket No. FDA–2023–N–3636]
Food and Drug Administration
Information Technology Strategy;
Request for Comments; Correction
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; correction.
The Food and Drug
Administration (FDA or Agency) is
correcting a notice entitled ‘‘Food and
Drug Administration Information
Technology Strategy; Request for
Comments’’ that appeared in the
Federal Register of September 19, 2023.
The document announced the
availability of an information
technology (IT) strategic plan entitled
the ‘‘FDA Information Technology
Strategy’’ and a request for comment on
this IT Strategy. The document was
published with an incorrect set of fiscal
SUMMARY:
ddrumheller on DSK120RN23PROD with NOTICES1
OPREinfocollection@acf.hhs.gov.
Identify all requests by the title of the
information collection.
SUPPLEMENTARY INFORMATION:
Description: Program monitoring is a
post-award process through which ACF
assesses a recipient’s programmatic
performance and business management
performance. Monitoring activities are
necessary to ensure timely action by
ACF to support grantees and protect
federal interests.
Program offices use information
collected under this generic clearance to
monitor funding recipient activities and
to provide support or take appropriate
action, as needed. The information
gathered is or will be used primarily for
internal purposes, but aggregate data
may be included in public materials
such as Reports to Congress or program
office documents. Following standard
OMB requirements, ACF will submit a
request for each individual data
VerDate Sep<11>2014
18:39 Oct 06, 2023
Jkt 262001
Dated: October 4, 2023.
Lauren K. Roth,
Associate Commissioner for Policy.
[FR Doc. 2023–22388 Filed 10–6–23; 8:45 am]
BILLING CODE 4164–01–P
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
[Docket No. FDA–2023–N–4202]
Revocation of Two Authorizations of
Emergency Use of In Vitro Diagnostic
Devices for Detection and/or Diagnosis
of Mpox; Availability
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
revocations of the Emergency Use
Authorizations (EUAs) (the
Authorizations) issued to Life
Technologies Corp. (a part of Thermo
Fisher Scientific Inc.), for the TaqPath
Monkeypox/Orthopox Virus DNA Kit,
and Becton, Dickinson and Co., for the
VIASURE Monkeypox virus Real Time
PCR Reagents for BD MAX System. FDA
revoked these Authorizations under the
Federal Food, Drug, and Cosmetic Act
(FD&C Act) as requested by these
Authorization holders. The revocations,
which include an explanation of the
reasons for each revocation, are
reprinted in this document.
DATES: The Authorization for the Life
Technologies Corp. (a part of Thermo
SUMMARY:
E:\FR\FM\10OCN1.SGM
10OCN1
]]>Agencies
[Federal Register Volume 88, Number 194 (Tuesday, October 10, 2023)]
[Notices]
[Pages 69931-69932]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-22382]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for Office of Management and Budget Review; Generic
for Administration for Children and Families Program Monitoring
Activities (Office of Management and Budget #: 0970-0558)
AGENCY: Office of Planning, Research, and Evaluation, Administration
for Children and Families, U.S. Department of Health and Human
Services.
ACTION: Request for public comments.
-----------------------------------------------------------------------
SUMMARY: The Administration for Children and Families (ACF) intends to
request from the Office of Management and Budget (OMB) an extension of
approval for an umbrella generic clearance for information collections
related to ACF program office monitoring activities. ACF programs
promote the economic and social well-being of families, children,
individuals, and communities. The Generic for ACF Program Monitoring
Activities allows ACF program offices to collect standardized
information from recipients that receive federal funds to ensure
oversight, evaluation, support purposes, and stewardship of federal
funds. There are no changes proposed to
[[Page 69932]]
the terms of the generic. Burden estimates have been updated.
DATES: Comments due within 30 days of publication. OMB must make a
decision about the collection of information between 30 and 60 days
after publication of this document in the Federal Register. Therefore,
a comment is best assured of having its full effect if OMB receives it
within 30 days of publication.
ADDRESSES: Written comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular
information collection by selecting ``Currently under 30-day Review-
Open for Public Comments'' or by using the search function. You can
also obtain copies of the proposed collection of information by
emailing [email protected]. Identify all requests by the
title of the information collection.
SUPPLEMENTARY INFORMATION:
Description: Program monitoring is a post-award process through
which ACF assesses a recipient's programmatic performance and business
management performance. Monitoring activities are necessary to ensure
timely action by ACF to support grantees and protect federal interests.
Program offices use information collected under this generic
clearance to monitor funding recipient activities and to provide
support or take appropriate action, as needed. The information gathered
is or will be used primarily for internal purposes, but aggregate data
may be included in public materials such as Reports to Congress or
program office documents. Following standard OMB requirements, ACF will
submit a request for each individual data collection activity under
this generic clearance. Each request will include the individual
form(s) or instrument(s), a justification specific to the individual
information collection, and any supplementary documents. OMB is
requested to review requests within 10 days of submission.
Respondents: ACF funding recipients.
Annual Burden Estimates
This request will extend approval of currently approved monitoring
forms. Currently approved forms and related burden can be found here:
https://www.reginfo.gov/public/do/PRAICList?ref_nbr=202307-0970-014.
Burden estimates for the next three years have been updated to
reflect trends in use over the past three years. These are based on
averages and actual individual requests will vary based on program
office need.
----------------------------------------------------------------------------------------------------------------
Number of
Number of responses per Avg. burden per
Instrument respondents respondent response (in Total burden
(total over (total over hours) (in hours)
request period) request period)
----------------------------------------------------------------------------------------------------------------
New Program Monitoring Forms............... 1600 2.5 12 48,000
----------------------------------------------------------------------------------------------------------------
Mary B. Jones,
ACF/OPRE Certifying Officer.
[FR Doc. 2023-22382 Filed 10-6-23; 8:45 am]
BILLING CODE 4184-79-P
